Validating the accuracy of continuous respiratory rate monitoring by the Airvo 3 device in healthy adults in motion: A comparison with a reference benchmark

Fisher & Paykel Healthcare0 个研究点目标入组 45 人开始时间: 2026年9月1日最近更新: 2026年8月24日

适应症

试验速览

暂无简介。

•Participants must have the ability to understand and provide written informed consent.
•Participants must be 18 years of age or older.
•The participant must feel in good general health.
•Participants must be able to walk and carry out required study movements without difficulty or assistance.
•Participants must be able to read and write in English.

•The participant has a previous clinical diagnosis of any chronic lung diseases including but not limited to asthma, COPD, cystic fibrosis, pulmonary fibrosis, pulmonary hypertension or congenital lung disease.
•Participants who have had a cardiovascular, kidney, or liver disease.
•Participants who are unable to tolerate nasal prongs.
•Participants who have had abdominal/ thoracic surgery in the last 180 days.
•Participants who have had any sinus or brain surgery in the last 180 days.
•Participants who have presented with symptoms of an upper respiratory tract infection in the past 14 days.
•Participants who have any other condition which in the opinion of investigators would make them unsuitable for the study.
•Participants with severe contact allergies to standard adhesives, latex or other materials found in pulse oximetry sensors, ECG electrodes, or other medical sensors (self-reported).
•Participants who refuse or are unable to sign an informed written consent for study.

发起方